{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:07:06Z","timestamp":1786122426918,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To systematically review the available evidence on electrochemotherapy (ECT) in pediatric patients, focusing on indications, treatment parameters, efficacy, and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>A systematic review was conducted in accordance with PRISMA guidelines and registered with PROSPERO (CRD42024575588). MEDLINE, Embase, and Cochrane Library databases were searched. Studies reporting the use of ECT in patients \u2264\u200918 years were included. Data extraction covered patient demographics, pathologies, electroporation parameters, agents used, and outcomes. Risk of bias was assessed using ROBINS-I.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Out of 1579 screened studies, 15 met the inclusion criteria, reporting at least 127 pediatric patients. Age was provided for 98 patients (pooled mean 8.5 years, range 0\u201317) and sex for 108 (58 female, 50 male). Two studies described tumors; the remainder reported vascular anomalies (VAs). Reversible electroporation with intralesional or intravenous bleomycin was the most common protocol. Complete response rates for tumors were 97\u2013100%. Pooled volume reductions in VAs ranged from 52% to 100%. Most complications were minor, though serious events occurred, including sciatic nerve injury, disseminated intravascular coagulation, and airway compromise. Methodological quality was low, with small sample sizes and inconsistent reporting of multiple parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>ECT is in the early stages of development but shows promising efficacy as a treatment for tumors and VAs in children. Preliminary data suggest favorable responses in children, although direct comparison with adults is limited. Further research is essential to establish standardized treatment guidelines, optimize safety, and define the role of ECT within pediatric oncology and interventional radiology. A minimum reporting dataset is proposed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Explain the unmet need\/clinical problem your study addresses. What is the current evidence regarding indications, efficacy, safety, and treatment parameters of ECT in pediatric patients?<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Fifteen studies, including 127 children, report high response rates for tumors and VAs, but evidence is limited by small cohorts and heterogeneous reporting<\/jats:italic>\n                      .\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>ECT shows promise as a minimally invasive treatment for selected pediatric tumors and VAs, but standardized protocols and large prospective studies are required before broader clinical adoption in pediatric oncology and interventional radiology<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-026-12554-z","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:37:35Z","timestamp":1776875855000},"page":"7278-7291","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Electrochemotherapy in pediatrics: a systematic review"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8320-1996","authenticated-orcid":false,"given":"M. A.","family":"Formstone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Neville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. N.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. C.","family":"Sedgwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Diez-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"12554_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0169-409X(98)00066-0","volume":"35","author":"LM Mir","year":"1999","unstructured":"Mir LM, Orlowski S (1999) Mechanisms of electrochemotherapy. Adv Drug Deliv Rev 35:107\u2013118","journal-title":"Adv Drug Deliv Rev"},{"key":"12554_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-925X-13-29","volume":"13","author":"D Miklav\u010di\u010d","year":"2014","unstructured":"Miklav\u010di\u010d D, Mali B, Kos B, Heller R, Ser\u0161a G (2014) Electrochemotherapy: from the drawing board into medical practice. Biomed Eng Online 13:29","journal-title":"Biomed Eng Online"},{"key":"12554_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.diii.2022.09.009","volume":"103","author":"JP Tasu","year":"2022","unstructured":"Tasu JP, Tougeron D, Rols MP (2022) Irreversible electroporation and electrochemotherapy in oncology: State of the art. Diagn Interv Imaging 103:499\u2013509","journal-title":"Diagn Interv Imaging"},{"key":"12554_CR4","unstructured":"Reber\u0161ek M, Miklav\u010di\u010d D (2010) Concepts of electroporation pulse generation and overview of electric pulse generators for cell and tissue electroporation. In: Miklav\u010di\u010d D (ed) Advanced electroporation techniques in biology and medicine. CRC Press, Boca Raton, pp 323\u2013339"},{"key":"12554_CR5","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1245\/s10434-008-9976-0","volume":"15","author":"P Quaglino","year":"2008","unstructured":"Quaglino P, Mortera C, Osella-Abate S et al (2008) Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 15:2215\u20132222","journal-title":"Ann Surg Oncol"},{"key":"12554_CR6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejso.2012.08.016","volume":"39","author":"B Mali","year":"2013","unstructured":"Mali B, Jarm T, Snoj M, Sersa G, Miklavcic D (2013) Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol 39:4\u201316","journal-title":"Eur J Surg Oncol"},{"key":"12554_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/bjr\/tqae231","volume":"98","author":"T Shiwani","year":"2025","unstructured":"Shiwani T, Singh Dhesi S, Wah TM (2025) Reversible electroporation for cancer therapy. Br J Radiol 98:313\u2013320","journal-title":"Br J Radiol"},{"key":"12554_CR8","unstructured":"IGEA Medical (2025) Why are the drugs selected for electrochemotherapy bleomycin and cisplatin? [Internet]. IGEA Medical, Modena"},{"key":"12554_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.bioelechem.2018.06.004","volume":"123","author":"A Prevc","year":"2018","unstructured":"Prevc A, Niksic Zakelj M, Kranjc S et al (2018) Electrochemotherapy with cisplatin or bleomycin in head and neck squamous cell carcinoma: Improved effectiveness of cisplatin in HPV-positive tumors. Bioelectrochemistry 123:248\u2013254.","journal-title":"Bioelectrochemistry"},{"key":"12554_CR10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ejso.2007.05.016","volume":"34","author":"G Sersa","year":"2008","unstructured":"Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M (2008) Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 34:232\u201340","journal-title":"Eur J Surg Oncol"},{"key":"12554_CR11","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/bjd.15340","volume":"176","author":"C Kunte","year":"2017","unstructured":"Kunte C, Letul\u00e9 V, Gehl J et al (2017) InspECT (the International Network for Sharing Practices on Electrochemotherapy). Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT. Br J Dermatol 176:1475\u20131485","journal-title":"Br J Dermatol"},{"key":"12554_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1245\/s10434-011-1860-7","volume":"19","author":"P Curatolo","year":"2012","unstructured":"Curatolo P, Quaglino P, Marenco F et al (2012) Electrochemotherapy in the treatment of Kaposi sarcoma cutaneous lesions: a two-center prospective phase II trial. Ann Surg Oncol 19:192\u20138","journal-title":"Ann Surg Oncol"},{"key":"12554_CR13","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ejca.2017.10.008","volume":"87","author":"CC Plaschke","year":"2017","unstructured":"Plaschke CC, Bertino G, McCaul JA et al (2017) European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: results from the treatment of mucosal cancers. Eur J Cancer 87:172\u2013181","journal-title":"Eur J Cancer"},{"key":"12554_CR14","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ejso.2019.11.509","volume":"46","author":"AJP Clover","year":"2020","unstructured":"Clover AJP, Salwa SP, Bourke MG et al (2020) Electrochemotherapy for the treatment of primary basal cell carcinoma; A randomised control trial comparing electrochemotherapy and surgery with five year follow up. Eur J Surg Oncol 46:847\u2013854","journal-title":"Eur J Surg Oncol"},{"key":"12554_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijsu.2015.04.055","volume":"18","author":"V Granata","year":"2015","unstructured":"Granata V, Fusco R, Piccirillo M et al (2015) Electrochemotherapy in locally advanced pancreatic cancer: preliminary results. Int J Surg 18:230\u20136.","journal-title":"Int J Surg"},{"key":"12554_CR16","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ejso.2020.04.037","volume":"46","author":"I Edhemovic","year":"2020","unstructured":"Edhemovic I, Brecelj E, Cemazar M et al (2020) Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study. Eur J Surg Oncol 46:1628\u20131633","journal-title":"Eur J Surg Oncol"},{"key":"12554_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejcsup.2006.08.002","volume":"4","author":"M Marty","year":"2006","unstructured":"Marty M, Sersa G, Garbay J et al (2006) Electrochemotherapy\u2014an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 4:3\u201313","journal-title":"Eur J Cancer Suppl"},{"key":"12554_CR18","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/bjr\/tqae219","volume":"98","author":"F Deschamps","year":"2025","unstructured":"Deschamps F, Tselikas L, Cazzato RL et al (2025) Electrochemotherapy in metastatic epidural spinal cord compression: a review and technical update. Br J Radiol 98:828\u2013839","journal-title":"Br J Radiol"},{"key":"12554_CR19","unstructured":"ISSVA Board (2018) ISSVA classification for vascular anomalies. International society for the study of vascular anomalies. Available from ISSVA. https:\/\/www.issva.org\/classification. Cited 15 Sept 2025"},{"key":"12554_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2478\/raon-2023-0029","volume":"57","author":"T Muir","year":"2023","unstructured":"Muir T, Bertino G, Groselj A et al (2023) Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report. Radiol Oncol 57:141\u2013149","journal-title":"Radiol Oncol"},{"key":"12554_CR21","doi-asserted-by":"publisher","unstructured":"Patel PA, Mu\u00f1oz FG (2026) Interventional oncology in children: Where are we now? J Med Imaging Radiat Oncol. https:\/\/doi.org\/10.1111\/1754-9485.13719","DOI":"10.1111\/1754-9485.13719"},{"key":"12554_CR22","doi-asserted-by":"publisher","first-page":"i4919","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919","journal-title":"BMJ"},{"key":"12554_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","volume":"12","author":"LA McGuinness","year":"2021","unstructured":"McGuinness LA, Higgins JPT (2021) Risk-of-bias visualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods 12:55\u201361","journal-title":"Res Synth Methods"},{"key":"12554_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2478\/raon-2024-0061","volume":"58","author":"T Muir","year":"2024","unstructured":"Muir T, Wohlgemuth WA, Cemazar M et al (2024) Current operating procedure (COP) for bleomycin electrosclerotherapy (BEST) of low-flow vascular malformations. Radiol Oncol 58:469\u2013479","journal-title":"Radiol Oncol"},{"key":"12554_CR25","doi-asserted-by":"publisher","first-page":"962","DOI":"10.2340\/00015555-2687","volume":"97","author":"E Balt\u00e1s","year":"2017","unstructured":"Balt\u00e1s E, Kis E, Nagy N et al (2017) Electrochemotherapy for non-melanoma skin cancer in a child with xeroderma pigmentosum. Acta Derm Venereol 97:962\u2013964","journal-title":"Acta Derm Venereol"},{"key":"12554_CR26","doi-asserted-by":"crossref","unstructured":"Dalm\u00e1dy S, Csoma Z, Besenyi Z et al (2020) New treatment option for capillary lymphangioma: bleomycin-based electrochemotherapy of an infant. Pediatrics 146:e20200566","DOI":"10.1542\/peds.2020-0566"},{"key":"12554_CR27","doi-asserted-by":"publisher","unstructured":"Goldann C, Deleu A, Sch\u00fcngel MS et al (2025) Bleomycin electrosclerotherapy (BEST) for treatment of slow-flow vascular malformations in children. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-025-04455-6","DOI":"10.1038\/s41390-025-04455-6"},{"key":"12554_CR28","first-page":"1167","volume":"12","author":"E Guida","year":"2025","unstructured":"Guida E, Boscarelli A, Zovko Z et al (2025) Bleomycin electrosclerotherapy for peripheral low-flow venous and lymphatic malformations in children: a monocentric case series. Children (Basel) 12:1167","journal-title":"Children (Basel)"},{"key":"12554_CR29","doi-asserted-by":"publisher","first-page":"162631","DOI":"10.1016\/j.jpedsurg.2025.162631","volume":"60","author":"J Haehl","year":"2025","unstructured":"Haehl J, Haeberle B, Muensterer O et al (2025) Bleomycin electrosclerotherapy (BEST) of slow-flow vascular malformations (SFVMs) in children. J Pediatr Surg 60:162631","journal-title":"J Pediatr Surg"},{"key":"12554_CR30","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1038\/s41598-019-41026-2","volume":"9","author":"EG Kis","year":"2019","unstructured":"Kis EG, Balt\u00e1s E, \u00d3csai H et al (2019) Electrochemotherapy in the treatment of locally advanced or recurrent eyelid-periocular basal cell carcinomas. Sci Rep 9:4285","journal-title":"Sci Rep"},{"key":"12554_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/DSS.0000000000003220","volume":"48","author":"M Kostusiak","year":"2022","unstructured":"Kostusiak M, Murugan S, Muir T (2022) Bleomycin electrosclerotherapy treatment in the management of vascular malformations. Dermatol Surg 48:67\u201371","journal-title":"Dermatol Surg"},{"key":"12554_CR32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s00270-024-03693-1","volume":"47","author":"JH Loeser","year":"2024","unstructured":"Loeser JH, Kisser U, Die\u00dfel L et al (2024) Interdisciplinary treatment of macroglossia due to a microcystic lymphatic malformation with bleomycin electrosclerotherapy followed by partial resection. Cardiovasc Intervent Radiol 47:852\u2013854","journal-title":"Cardiovasc Intervent Radiol"},{"key":"12554_CR33","doi-asserted-by":"publisher","unstructured":"Loeser JH, Guntau M, Bidakov O et al (2025) Therapy of lymphatic malformations or isolated lymphatic components in combined slow-flow malformations with bleomycin electrosclerotherapy (BEST). Rofo. https:\/\/doi.org\/10.1055\/a-2648-6555","DOI":"10.1055\/a-2648-6555"},{"key":"12554_CR34","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1007\/s00270-025-04169-6","volume":"48","author":"F Obereisenbuchner","year":"2025","unstructured":"Obereisenbuchner F, Borisch E, Puhr-Westerheide D et al (2025) Safety and clinical outcome of bleomycin-electrosclerotherapy (BEST) treating lymphatic malformations (LMs). Cardiovasc Intervent Radiol 48:1428\u20131437","journal-title":"Cardiovasc Intervent Radiol"},{"key":"12554_CR35","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1007\/s00270-025-04178-5","volume":"48","author":"F Obereisenbuchner","year":"2025","unstructured":"Obereisenbuchner F, Schmidt VF, Goldann C et al (2025) Combining reversible electroporation and bleomycin in treatment of arteriovenous malformations. Cardiovasc Intervent Radiol 48:1632\u20131637","journal-title":"Cardiovasc Intervent Radiol"},{"key":"12554_CR36","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1007\/s00330-024-10723-6","volume":"34","author":"VF Schmidt","year":"2024","unstructured":"Schmidt VF, Cangir \u00d6, Meyer L et al (2024) Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children. Eur Radiol 34:6425\u20136434","journal-title":"Eur Radiol"},{"key":"12554_CR37","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3390\/jcm13051239","volume":"13","author":"G Tedesco","year":"2024","unstructured":"Tedesco G, Noli LE, Griffoni C et al (2024) Electrochemotherapy in aggressive hemangioma of the spine: a case series and narrative literature review. J Clin Med 13:1239","journal-title":"J Clin Med"},{"key":"12554_CR38","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3390\/biomedicines13051055","volume":"13","author":"V Vielsmeier","year":"2025","unstructured":"Vielsmeier V, Schmidt VF, Obereisenbuchner F et al (2025) Bleomycin electrosclerotherapy (BEST) for slow-flow malformations of the upper aerodigestive tract. Biomedicines 13:1055","journal-title":"Biomedicines"},{"key":"12554_CR39","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jvsv.2020.09.009","volume":"9","author":"WA Wohlgemuth","year":"2021","unstructured":"Wohlgemuth WA, M\u00fcller-Wille R, Meyer L et al (2021) Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body. J Vasc Surg Venous Lymphat Disord 9:731\u2013739","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"12554_CR40","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1080\/0284186X.2018.1454602","volume":"57","author":"J Gehl","year":"2018","unstructured":"Gehl J, Sersa G, Matthiessen LW et al (2018) Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 57:874\u2013882","journal-title":"Acta Oncol"},{"key":"12554_CR41","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1007\/s00270-024-03772-3","volume":"47","author":"DK Filippiadis","year":"2024","unstructured":"Filippiadis DK, Pereira PL, Hausegger KA, Binkert CA (2024) CIRSE classification system for complications\u2019 reporting: a project evaluation process. Cardiovasc Intervent Radiol 47:1160\u20131162","journal-title":"Cardiovasc Intervent Radiol"},{"key":"12554_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/diagnostics13020209","volume":"13","author":"V Granata","year":"2023","unstructured":"Granata V, Fusco R, D'Alessio V et al (2023) Percutanous electrochemotherapy (ECT) in primary and secondary liver malignancies: a systematic review. Diagnostics (Basel) 13:209","journal-title":"Diagnostics (Basel)"},{"key":"12554_CR43","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2478\/raon-2022-0022","volume":"56","author":"FM Schipilliti","year":"2022","unstructured":"Schipilliti FM, Onorato M, Arrivi G et al (2022) Electrochemotherapy for solid tumors: literature review and presentation of a novel endoscopic approach. Radiol Oncol 56:285\u2013291","journal-title":"Radiol Oncol"},{"key":"12554_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1146\/annurev-biophys-052118-115451","volume":"48","author":"T Kotnik","year":"2019","unstructured":"Kotnik T, Rems L, Tarek M, Miklav\u010di\u010d D (2019) Membrane electroporation and electropermeabilization: mechanisms and models. Annu Rev Biophys 48:63\u201391","journal-title":"Annu Rev Biophys"},{"key":"12554_CR45","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.3390\/cancers15051598","volume":"15","author":"AE Spiliotis","year":"2023","unstructured":"Spiliotis AE, Holl\u00e4nder S, Rudzitis-Auth J et al (2023) Evaluation of electrochemotherapy with bleomycin in the treatment of colorectal hepatic metastases in a rat model. Cancers (Basel) 15:1598","journal-title":"Cancers (Basel)"},{"key":"12554_CR46","doi-asserted-by":"publisher","first-page":"1470432","DOI":"10.3389\/fimmu.2025.1470432","volume":"16","author":"K Ur\u0161i\u010d Valentinuzzi","year":"2025","unstructured":"Ur\u0161i\u010d Valentinuzzi K, Kamen\u0161ek U, Kranjc Brezar S et al (2025) Electrochemotherapy with bleomycin, oxaliplatin, or cisplatin in mouse tumor models, from tumor ablation to in situ vaccination. Front Immunol 16:1470432","journal-title":"Front Immunol"},{"key":"12554_CR47","doi-asserted-by":"publisher","first-page":"153303381878532","DOI":"10.1177\/1533033818785329","volume":"17","author":"U Probst","year":"2018","unstructured":"Probst U, Fuhrmann I, Beyer L, Wiggermann P (2018) Electrochemotherapy as a new modality in interventional oncology: a review. Technol Cancer Res Treat 17:1533033818785329","journal-title":"Technol Cancer Res Treat"},{"key":"12554_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s10439-023-03309-8","volume":"52","author":"W Peng","year":"2024","unstructured":"Peng W, Polaj\u017eer T, Yao C, Miklav\u010di\u010d D (2024) Dynamics of cell death due to electroporation using different pulse parameters as revealed by different viability assays. Ann Biomed Eng 52:22\u201335","journal-title":"Ann Biomed Eng"},{"key":"12554_CR49","doi-asserted-by":"publisher","first-page":"107871","DOI":"10.1016\/j.bioelechem.2021.107871","volume":"141","author":"T Batista Napotnik","year":"2021","unstructured":"Batista Napotnik T, Polaj\u017eer T, Miklav\u010di\u010d D (2021) Cell death due to electroporation\u2014a review. Bioelectrochemistry 141:107871","journal-title":"Bioelectrochemistry"},{"key":"12554_CR50","unstructured":"Lee EW, Totonchy M, Kee ST (2011) Irreversible electroporation ablation: mechanism of action and devices. In: Hong K, Georgiades CS (eds) Percutaneous tumor ablation: strategies and techniques. Georg Thieme Verlag, Stuttgart"},{"key":"12554_CR51","first-page":"147","volume":"20","author":"AR Deipolyi","year":"2014","unstructured":"Deipolyi AR, Golberg A, Yarmush ML, Arellano RS, Oklu R (2014) Irreversible electroporation: evolution of a laboratory technique in interventional oncology. Diagn Interv Radiol 20:147\u201354","journal-title":"Diagn Interv Radiol"},{"key":"12554_CR52","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s10439-020-02462-8","volume":"48","author":"B Mercadal","year":"2020","unstructured":"Mercadal B, Beitel-White N, Aycock KN, Castellv\u00ed Q, Davalos RV, Ivorra A (2020) Dynamics of cell death after conventional IRE and H-FIRE treatments. Ann Biomed Eng 48:1451\u20131462","journal-title":"Ann Biomed Eng"},{"key":"12554_CR53","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3390\/jcm10081609","volume":"10","author":"ZL Rai","year":"2021","unstructured":"Rai ZL, Feakins R, Pallett LJ, Manas D, Davidson BR (2021) Irreversible electroporation (IRE) in locally advanced pancreatic cancer: a review of current clinical outcomes, mechanism of action and opportunities for synergistic therapy. J Clin Med 10:1609","journal-title":"J Clin Med"},{"key":"12554_CR54","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1007\/s00270-014-0932-z","volume":"37","author":"G Chaudry","year":"2014","unstructured":"Chaudry G, Guevara CJ, Rialon KL et al (2014) Safety and efficacy of bleomycin sclerotherapy for microcystic lymphatic malformation. Cardiovasc Intervent Radiol 37:1476\u201381","journal-title":"Cardiovasc Intervent Radiol"},{"key":"12554_CR55","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PRS.0000000000001924","volume":"137","author":"SER Horbach","year":"2016","unstructured":"Horbach SER, Rigter IM, Smitt JHS, Reekers JA, Spuls PI, van der Horst CMAM (2016) Intralesional bleomycin injections for vascular malformations: a systematic review and meta-analysis. Plast Reconstr Surg 137:244\u2013256","journal-title":"Plast Reconstr Surg"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12554-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-026-12554-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-026-12554-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T10:09:29Z","timestamp":1786097369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-026-12554-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["12554"],"URL":"https:\/\/doi.org\/10.1007\/s00330-026-12554-z","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The scientific guarantor of this publication is Dr Matthew Formstone.","order":1,"name":"Ethics","label":"Guarantor","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No complex statistical methods were necessary for this paper.","order":3,"name":"Ethics","label":"Statistics and biometry","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"n\/a.","order":4,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Institutional Review Board approval was not required because of the nature of this study.","order":5,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This is the first systematic review on this topic.","order":6,"name":"Ethics","label":"Study subjects or cohorts overlap","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"order":7,"name":"Ethics","label":"Methodology","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}